Lodgement of Nyrada Inc Prospectus - Initial Public Offering
Filed with ASX · · 138 pages · English
Story so far
Earlier from Noxopharm
- Noxopharm Announces Appointment of Chief Commercial Officer
- Appendix 4C - Quarterly
- Dr Graham Kelly to Assume CEO Role
- Durable Anti-Cancer Effect Confirmed in DARRT-1 Study
- Potential Fundamental Change in Treatment of Brain Cancer
Later from Noxopharm
- Positive DARRT-1 Data in Late-Stage Prostate Cancer
- Nyrada Inc Initial Public Offering Opens
- Lodgement of Nyrada Inc Supplementary Prospectus
- Nyrada IPO Offer Fully Subscribed
- DARRT-1 Clinical Data Webinar
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm